Form 13-F position report

OSMOTICA PHARMACEUTICALS PL

Reported by ALLIANCEBERNSTEIN L P

RVLPQ CUSIP G6S41R101 Manager CIK 0001109448

Reported 0 shares, down 215,540 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2021
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 6 Through Q2 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for OSMOTICA PHARMACEUTICALS PL held by ALLIANCEBERNSTEIN L P.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

65 managers reported OSMOTICA PHARMACEUTICALS PL for Q2 2021.

Managers reporting OSMOTICA PHARMACEUTICALS PL in Q2 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
MORGAN STANLEY Reduced 1,668,279 -262,502 < 0.01% $5,021,000 11 qtrs
RENAISSANCE TECHNOLOGIES LLC Added 973,102 +6,595 < 0.01% $2,929,000 9 qtrs
JACOBS LEVY EQUITY MANAGEMENT INC Reduced 339,129 -69,489 < 0.01% $1,021,000 2 qtrs
Rovida Advisors Inc New 300,308 +300,308 0.04% $901,000 1 qtr
VANGUARD GROUP INC Reduced 210,434 -57,973 < 0.01% $634,000 11 qtrs
BlackRock Inc Reduced 167,250 -1,150,685 < 0.01% $503,000 11 qtrs
MILLENNIUM MANAGEMENT LLC New 160,140 +160,140 < 0.01% $482,000 1 qtr
GEODE CAPITAL MANAGEMENT LLC Reduced 155,718 -85,013 < 0.01% $468,000 11 qtrs
Squarepoint Ops LLC Reduced 80,827 -85,336 < 0.01% $243,000 7 qtrs
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Reduced 61,991 -23,870 < 0.01% $187,000 11 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2021
Filed
July 30, 2021
Filing type
13F-HR
Position type
SHS

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.